The risks of malignancy for cytologic categories in renal biopsy specimens differ from the risks in most other sites. There are obvious areas in which cytopathologists can do better at classifying these cases, and the routine use of immunohistochemistry and core-needle biopsy may improve the accuracy of the classification of these specimens.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/cncy.22759 | DOI Listing |
Publication Analysis
Top Keywords
renal biopsy
8
risk malignancy
4
malignancy renal
4
biopsy review
4
review risks
4
risks malignancy
4
malignancy cytologic
4
cytologic categories
4
categories renal
4
biopsy specimens
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!